Epidemiology & Genomics Research Program
Supporting research in human populations to understand determinants of cancer occurrence and outcomes and translating findings to clinical and public health interventions.
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts
PAR-22-161 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
Research Opportunities in Established Cancer Epidemiology Cohort Studies
PAR-22-162 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
Exploratory Grants in Cancer Control
PAR-21-341 (R21 - Clinical Trial Optional)
Expires October 9, 2024
Time-Sensitive Obesity Policy and Program Evaluation
PAR-21-305 (R01 - Clinical Trial Not Allowed)
Expires September 11, 2024
Notice of Special Interest: Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
Expires March 9, 2024
Modular R01s in Cancer Control and Population Sciences
PAR-21-190 (R01 - Clinical Trial Optional)
Expires March 8, 2024
Notice of Special Interest: Understanding the Effects of Cancer and Cancer Treatment on Aging Trajectories and Aging Outcomes
Expires January 8, 2024
Assay Validation of High Quality Markers for Clinical Studies in Cancer
Notice of Special Interest: Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults
Expires May 08, 2023
2022 Version of Automated Self-Administered 24-Hour (ASA24) Dietary Assessment Tool Now Available
The Automated Self-Administered 24-hour (ASA24®) Dietary Assessment Tool is a free, web-based tool that enables multiple, automatically coded, self-administered 24-hour diet recalls and/or single or multi-day food records for epidemiologic, intervention, behavioral, or clinical research.
Funding Opportunities to Address Benefits and Harms of Cannabis Use Among Cancer Patients
Although there has been a rapid increase in the availability of cannabis and cannabinoid products and substantial changes in their delivery methods, there is not yet enough information available regarding the harms and benefits of these substances during cancer treatment. Read our monthly newsletter to learn about NCI support for research addressing cannabis and cannabinoid use among cancer patients.
Open Fellowship Opportunities
Please share our fellowship opportunities for training in clinical epidemiology; genetic epidemiology; diet, physical activity, and/or sleep assessment, and communication.